We are live on ! Find out more
SRC

Stone Run Capital Portfolio holdings

AUM $254M
1-Year Est. Return 12.86%
This Fund
S&P 500
This Quarter Est. Return
+9.6%
1 Year Est. Return
+12.86%
3 Year Est. Return
+77.77%
5 Year Est. Return
+98.28%
10 Year Est. Return
+404.21%
AUM
$283M
AUM Growth
+$21.8M
Cap. Flow
-$926K
Cap. Flow %
-0.33%
Top 10 Hldgs %
37.55%
Holding
67
New
3
Increased
14
Reduced
21
Closed
3

Top Buys

Rank Stock Value
1
CLVT icon
Clarivate
CLVT
+$4.01M
2
DIS icon
Walt Disney
DIS
+$2.56M
3
TFX icon
Teleflex
TFX
+$1.04M
4
ANET icon
Arista Networks
ANET
+$610K
5
FISV
Fiserv Inc
FISV
+$564K

Top Sells

Rank Stock Value
1
VRSK icon
Verisk Analytics
VRSK
+$3.39M
2
LIN icon
Linde
LIN
+$1.53M
3
VAR
Varian Medical Systems, Inc.
VAR
+$1.21M
4
BDX icon
Becton Dickinson
BDX
+$737K
5
IFF icon
International Flavors & Fragrances
IFF
+$639K

Sector Composition

Rank Sector Weight
1 Technology 30.43%
2 Healthcare 28.12%
3 Industrials 15.06%
4 Materials 14.55%
5 Communication Services 5.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ADSK icon
1
Autodesk
ADSK
$49.5B
$12.1M 4.27%
41,435
+100
+0.2% +$28.5K
INFO
2
DELISTED
IHS Markit Ltd. Common Shares
INFO
$11.8M 4.17%
104,830
– –
TECH icon
3
Bio-Techne
TECH
$11.2B
$11.8M 4.16%
104,800
+1,200
+1% +$126K
DHR icon
4
Danaher
DHR
$137B
$11M 3.88%
46,232
+169
+0.4% +$37.5K
EPAM icon
5
EPAM Systems
EPAM
$5.51B
$10.9M 3.84%
21,320
– –
MLM icon
6
Martin Marietta Materials
MLM
$31.5B
$10.2M 3.6%
29,030
-500
-2% -$178K
IFF icon
7
International Flavors & Fragrances
IFF
$20.2B
$10.2M 3.6%
68,286
-4,450
-6% -$639K
EW icon
8
Edwards Lifesciences
EW
$49.6B
$9.63M 3.4%
93,025
+500
+0.5% +$47.1K
TMO icon
9
Thermo Fisher Scientific
TMO
$213B
$9.43M 3.33%
18,695
+127
+0.7% +$59.9K
ROP icon
10
Roper Technologies
ROP
$38.8B
$9.37M 3.3%
19,927
-560
-3% -$248K
LIN icon
11
Linde
LIN
$221B
$8.51M 3%
29,420
-5,250
-15% -$1.53M
BDX icon
12
Becton Dickinson
BDX
$45.6B
$8.45M 2.98%
35,634
-3,074
-8% -$737K
HEI icon
13
HEICO Corp
HEI
$49.8B
$7.9M 2.79%
56,634
-50
-0.1% -$6.9K
RVTY icon
14
Revvity
RVTY
$12.6B
$7.67M 2.71%
49,675
-2,425
-5% -$341K
ANSS
15
DELISTED
Ansys
ANSS
$7.61M 2.69%
21,940
– –
BRK.B icon
16
Berkshire Hathaway Class B
BRK.B
$1.1T
$7.47M 2.63%
26,875
-150
-0.6% -$41.9K
STE icon
17
Steris
STE
$22.3B
$7.44M 2.62%
36,050
+2,000
+6% +$403K
PAYX icon
18
Paychex
PAYX
$41.6B
$7.07M 2.49%
65,842
-1,600
-2% -$161K
FISV
19
Fiserv Inc
FISV
$28.8B
$6.75M 2.38%
63,122
+4,850
+8% +$564K
MKC icon
20
McCormick & Company Non-Voting
MKC
$13.7B
$6.66M 2.35%
75,350
+400
+0.5% +$35.7K
TFX icon
21
Teleflex
TFX
$6.05B
$6.37M 2.25%
15,865
+2,550
+19% +$1.04M
IT icon
22
Gartner
IT
$10.1B
$6.31M 2.23%
26,066
-991
-4% -$217K
LII icon
23
Lennox International
LII
$14.4B
$6.19M 2.18%
17,650
– –
WTS icon
24
Watts Water Technologies
WTS
$11.5B
$5.76M 2.03%
39,450
– –
SHW icon
25
Sherwin-Williams
SHW
$82.7B
$5.48M 1.93%
20,115
– –
1
2 3

Similar funds

TCB
Texas Capital Bancshares Dallas, Texas $254M AUM 27.01% 1-Year Est. Return
OIA
Optimum Investment Advisors Chicago, Illinois $252M AUM 26.44% 1-Year Est. Return
SSW
Smith Shellnut Wilson Ridgeland, Mississippi $260M AUM 19.19% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
WS
Wela Strategies Atlanta, Georgia $264M AUM 16.32% 1-Year Est. Return
MTWM
Masso Torrence Wealth Management Marlton, New Jersey $240M AUM 26.41% 1-Year Est. Return
KSWA
Kathleen S. Wright Associates Pittsburgh, Pennsylvania $270M AUM 12.59% 1-Year Est. Return
GA
Guerra Advisors Miami, Florida $271M AUM 27.78% 1-Year Est. Return

Stone Run Capital's Q2 2021 Portfolio in Review

As of Q2 2021, Stone Run Capital held 67 positions worth $283M, up 8.3% from $262M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Stone Run Capital's Q2 2021 filing shows 3 new, 14 increased, 21 reduced and 3 closed positions. Its largest new stake was Clarivate: 145,800 shares worth $4.01M. The largest sale was Verisk Analytics, an estimated $3.39M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 29% a quarter earlier, followed by Healthcare and Industrials.

  • Stone Run Capital's largest Q2 2021 buy was Clarivate: 145,800 shares worth $4.01M.
  • Stone Run Capital added most to Teleflex in Q2 2021, an estimated $1.04M increase.
  • Stone Run Capital's biggest Q2 2021 reduction was Verisk Analytics, cutting an estimated $3.39M.
  • Stone Run Capital fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $1.21M.
  • Stone Run Capital's ten largest holdings make up 38% of its $283M portfolio in Q2 2021.
  • Stone Run Capital opened 3 new positions and closed 3 in Q2 2021.
  • Stone Run Capital's portfolio value rose 8.3% quarter-over-quarter to $283M.

Based on Stone Run Capital's 13F filing for Q2 2021, filed 16 Aug 2021.